Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics, Inc. | 0.05% | 124.45 | 4.2% | $162.83m | |
| IQV | IQVIA Holdings, Inc. | -0.03% | 187.73 | 0.0% | $140.51m | |
| LH | Laboratory Corp. of America Holdings | 0.05% | 223.81 | 2.4% | $131.47m | |
| SYNH | Syneos Health, Inc. | 0.00% | 75.42 | 0.0% | $51.94m | |
| AMEH | Apollo Medical Holdings, Inc. | 0.00% | 21.67 | 0.0% | $2.47m | |
| BASI | Bioanalytical Systems, Inc. | 0.00% | 15.60 | 0.2% | $2.41m | |
| NRC | National Research Corp. | 0.00% | 46.62 | 0.0% | $1.57m | |
| PLX | Protalix Biotherapeutics, Inc. | 0.00% | 4.17 | 25.3% | $0.70m | |
| IDXG | Interpace Biosciences, Inc. | 0.00% | 4.10 | 22.8% | $0.48m | |
| PMD | Psychemedics Corp. | 0.00% | 4.95 | 0.7% | $0.34m |
Company Profile
IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.